Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013.
Recently, the gene therapy field has begun to experience clinical successes in a number of different diseases using various approaches and vectors. The workshop Gene Therapy: Charting a Future Course, sponsored by the National Institutes of Health (NIH) Office of Biotechnology Activities, brought together early and mid-career researchers to discuss the key scientific challenges and opportunities, ethical and communication issues, and NIH and foundation resources available to facilitate further clinical advances.
1 Office of Science Policy, Office of the Director, National Institutes of Health , Bethesda, MD 20892.
Marina
M
O'Reilly
Howard J
HJ
Federoff
Yuman
Y
Fong
Donald B
DB
Kohn
Amy P
AP
Patterson
Nabil
N
Ahmed
Aravind
A
Asokan
Shannon E
SE
Boye
Ronald G
RG
Crystal
Satiro
S
De Oliveira
Linda
L
Gargiulo
Scott Q
SQ
Harper
Yasuhiro
Y
Ikeda
Robert
R
Jambou
Maureen
M
Montgomery
Lawrence
L
Prograis
Eugene
E
Rosenthal
Daniel H
DH
Sterman
Luk H
LH
Vandenberghe
Laurie
L
Zoloth
Mehrdad
M
Abedi
Jennifer
J
Adair
Prasad S
PS
Adusumilli
William F
WF
Goins
Jhanelle
J
Gray
Paul
P
Monahan
Leslie
L
Popplewell
Miguel
M
Sena-Esteves
Bakhos
B
Tannous
Thomas
T
Weber
William
W
Wierda
Rashmi
R
Gopal-Srivastava
Cheryl L
CL
McDonald
Daniel
D
Rosenblum
Jacqueline
J
Corrigan-Curay
D000818:Animals; D004496:Education, Continuing; D036281:Genetic Research; D015316:Genetic Therapy / Q000191:economics / Q000941:ethics* / Q000331:legislation & jurisprudence; D005822:Genetic Vectors; D006801:Humans; D009316:National Institutes of Health (U.S.); D057905:Stem Cell Research; D033581:Stem Cell Transplantation; D014161:Transduction, Genetic; D014481:United States